The activators for Zinc Finger CCHC-Type Containing 8 (ZCCHC8) target a range of cellular processes and signaling pathways, thereby indirectly influencing ZCCHC8 activity. These compounds mainly act on RNA processing, transcription regulation, and related signaling pathways. Spliceosome inhibitors like Pladienolide B can offer insights into the splicing processes in which ZCCHC8 may be involved. HDAC inhibitors and BET bromodomain inhibitors affect chromatin structure and transcription, impacting ZCCHC8's role in RNA processing.
RNA Polymerase II inhibitors and transcription elongation inhibitors like DRB can affect the production and processing of RNA, providing insights into ZCCHC8's function. mTOR inhibitors and modulators of the SMN protein complex or U1 snRNP can also influence RNA processing and splicing regulation, affecting ZCCHC8. Leptomycin B and actinomycin D, affecting RNA synthesis and export, might indirectly influence ZCCHC8. HSP90 inhibitors can impact protein stability and response to cellular stress, possibly affecting the function of RNA processing proteins like ZCCHC8.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitors can affect chromatin structure and gene expression, potentially influencing ZCCHC8. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
These inhibitors affect transcription, potentially impacting RNA processing and ZCCHC8's role. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitors can affect various cellular processes, including RNA processing, possibly impacting ZCCHC8. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits nuclear export of RNA and proteins, potentially impacting ZCCHC8's involvement in RNA processing. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA synthesis; used in studies of RNA processing and may indirectly affect ZCCHC8. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits transcription elongation, potentially affecting RNA processing involving ZCCHC8. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
HSP90 inhibitors can affect protein stability and cellular stress responses, potentially impacting ZCCHC8's function. | ||||||